Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design-Reference-Cited by-同舟云学术

Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design

Published:2023-09 Issue: Volume:191 Page:112979
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Zhang Dan,Gu Min

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference8 articles.

1. Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design;van Hulst;Eur J Cancer,2023

2. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer;Mulhern;J Clin Oncol,2004

3. Psychiatric morbidity in Egyptian children with acute lymphoblastic leukemia and their care providers;Khalifa;Hematol Oncol Stem Cell Ther,2014

4. Parental adjustment following their child's completion of acute lymphoblastic leukemia treatment;McCarthy;Pediatr Blood Cancer,2021

5. Care burden and its predictive factors in parents of newly diagnosed children with acute lymphoblastic leukemia in academic hospitals in China;Wang;Support Care Cancer,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design;European Journal of Cancer;2023-09